Josep Bassaganya-Riera insider trades: Landos Biopharma (LABP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Josep reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | LABP | ↓ Sell | 93,495 | $4.88 | $456K | by trust | Dec 20, 2021 (0d) |
| Dec 15, 2021 | LABP | ↓ Sell | 125,000 | $5.16 | $645K | by trust | Dec 15, 2021 (0d) |
| Dec 10, 2021 | LABP | ↓ Sell | 51,162 | $5.88 | $301K | by trust | Dec 10, 2021 (0d) |
| Dec 8, 2021 | LABP | ↓ Sell | 103,530 | $6.45 | $668K | by trust | Dec 8, 2021 (0d) |
| Dec 3, 2021 | LABP | ↓ Sell | 98,098 | $6.53 | $640K | by trust | Dec 3, 2021 (0d) |
| Nov 30, 2021 | LABP | ↓ Sell | 50,430 | $7.22 | $364K | by trust | Dec 1, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Josep Bassaganya-Riera's insider trades
Josep Bassaganya-Riera is a 10% owner of Landos Biopharma (LABP). Since Nov 30, 2021, Josep has reported no open-market purchases and 6 sales worth $3.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LABP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.